LOINC parts

72,372 parts · page 1431 of 1,448 · all codes

PartNameTypeTests
LP97055-5 Type of client COMPONENT 1
LP97056-3 Type of encounter COMPONENT 3
LP97057-1 Hours designated COMPONENT 1
LP97058-9 Care capacity COMPONENT 1
LP97059-7 Care provided COMPONENT 1
LP97060-5 Volume of nursing delivery unit or service panel COMPONENT 1
LP97061-3 Method of care delivery COMPONENT 1
LP97103-3 Newborn Screening Report summary panel COMPONENT 1
LP97104-1 Full newborn screening summary report for display or printing COMPONENT 1
LP97105-8 Newborn screening report - overall interpretation COMPONENT 1
LP97106-6 Newborn conditions with positive markers COMPONENT 1
LP97107-4 CYP2C19 gene COMPONENT
LP97117-3 Referral note COMPONENT 91
LP97118-1 Cardiovascular disease METHOD 44
LP97119-9 Geriatric medicine METHOD 37
LP97120-7 Hematology+Medical oncology METHOD 27
LP97123-1 Orthopedic surgery METHOD 2
LP97124-9 Otolaryngology METHOD 26
LP97125-6 Pulmonary disease METHOD 25
LP97126-4 Critical care medicine METHOD 21
LP97127-2 Obstetrics and Gynecology METHOD 30
LP97129-8 Lupus anticoagulant neutralization.high phospholipid DIVISORS
LP97133-0 OASIS-C METHOD 41
LP97134-8 Date of Physician-ordered Start of Care (Resumption of Care) COMPONENT 1
LP97135-5 Risk factors affecting health status and or outcome COMPONENT 1
LP97139-7 Reason pneumococcal vaccine not given COMPONENT 1
LP97140-5 Patient lives alone COMPONENT 1
LP97141-3 Patient lives with other person COMPONENT 1
LP97142-1 Patient lives in congregated situtation COMPONENT 1
LP97150-4 Pressure ulcer assessment COMPONENT
LP97152-0 Number of pressure ulcers - unstageable due to non-removable dressing or device COMPONENT 1
LP97156-1 Pressure ulcer width COMPONENT 1
LP97159-5 Current number of stage 1 pressure ulcers COMPONENT 1
LP97165-2 Symptoms in heart failure patients COMPONENT 1
LP97170-2 Self-care COMPONENT 1
LP97172-8 Transfer COMPONENT 1
LP97173-6 Medication intervention COMPONENT
LP97174-4 Patient/caregiver received high risk drug education COMPONENT 1
LP97180-1 Supervision and safety COMPONENT
LP97181-9 Advocacy or facilitation of patient participation COMPONENT
LP97182-7 ADL or IADL assistance frequency from any caregiver COMPONENT 1
LP97183-5 Patient-specific parameters for notifying physician of changes COMPONENT
LP97186-8 Medication follow-up COMPONENT 2
LP97187-6 Patient/caregiver drug education intervention COMPONENT 2
LP97188-4 Date of Referral COMPONENT 1
LP97189-2 Episode Timing COMPONENT 1
LP97194-2 Formal pain assessment using standardized tool COMPONENT 1
LP97195-9 Heart failure follow-up COMPONENT 1
LP97196-7 Depression screening COMPONENT
LP97197-5 Household tasks COMPONENT 1

← prev · next →